Search

Your search keyword '"Kfoury, Abdallah G."' showing total 98 results

Search Constraints

Start Over You searched for: Author "Kfoury, Abdallah G." Remove constraint Author: "Kfoury, Abdallah G." Publisher elsevier bv Remove constraint Publisher: elsevier bv
98 results on '"Kfoury, Abdallah G."'

Search Results

1. HEALTH RELATED QUALITY OF LIFE AS PREDICTOR OF OUTCOMES IN HEART FAILURE WITH PRESERVED EJECTION FRACTION

2. SPHINGOLIPIDS AS POTENTIAL SURROGATES OF MYOCARDIAL RECOVERY IN LEFT VENTRICULAR ASSIST DEVICE PATIENTS

3. IMPAIRED LIVER FUNCTION IS ASSOCIATED WITH HYPOTENSION AND ELEVATED RIGHT ATRIAL PRESSURE BUT NOT DEPRESSED CARDIAC INDEX IN CHRONIC HEART FAILURE

4. Bias in Medicine

5. Risk score–guided multidisciplinary team-based Care for Heart Failure Inpatients is associated with lower 30-day readmission and lower 30-day mortality

6. Post-transplant outcome in patients bridged to transplant with temporary mechanical circulatory support devices

7. Accelerated Allograft Vasculopathy With Rituximab After Cardiac Transplantation

8. Early immune biomarkers and intermediate-term outcomes after heart transplantation: Results of Clinical Trials in Organ Transplantation-18

9. Health Related Quality of Life in Heart Failure Patients with Improved Ejection Fraction

11. Implementation of Real-Time Assessment of Patient-Reported Outcomes in a Heart Failure Clinic: A Feasibility Study

15. Association of recipient age and causes of heart transplant mortality: Implications for personalization of post-transplant management—An analysis of the International Society for Heart and Lung Transplantation Registry

17. Early inpatient calculation of laboratory-based 30-day readmission risk scores empowers clinical risk modification during index hospitalization

19. Evidence of Glycolysis Up-Regulation and Pyruvate Mitochondrial Oxidation Mismatch During Mechanical Unloading of the Failing Human Heart

20. Impact of Ischemic Heart Failure Etiology on Cardiac Recovery During Mechanical Unloading

21. Immunologic effects of continuous-flow left ventricular assist devices before and after heart transplant

22. Myocardial Structural and Functional Response After Long-Term Mechanical Unloading With Continuous Flow Left Ventricular Assist Device

23. ISHLT pathology antibody mediated rejection score correlates with increased risk of cardiovascular mortality: A retrospective validation analysis

24. Mixed cellular and antibody-mediated rejection in heart transplantation: In-depth pathologic and clinical observations

26. Gene expression profiling to study racial differences after heart transplantation

27. Reply

29. Comparing velour versus silicone interfaces at the driveline exit site of HeartMate II devices: infection rates, histopathology, and ultrastructural aspects

30. Myocardial Atrophy and Chronic Mechanical Unloading of the Failing Human Heart

31. Determinants of Waiting List Time for Heart Transplantation: Is It All About Sensitization?

32. Late Antibody-Mediated Rejection (AMR) in Heart Transplantation: How “Late” Is It?

34. Reply

35. Decreased Myocardial Inflammatory Markers in the Failing Human Heart after Continuous Flow Left Ventricular Assist Device-Induced Mechanical Unloading

36. Regional Structural Uniformity of Left Ventricular Remodeling in Patients with Advanced Non Ischemic Cardiomyopathy

38. Magnitude and Time Course of Changes Induced by Continuous-Flow Left Ventricular Assist Device Unloading in Chronic Heart Failure

39. Longitudinal evaluation of microvessel density in survivors vs. nonsurvivors of cardiac pathologic antibody-mediated rejection

40. Lactic Acidosis After Cardiac Transplantation: Foe or Common Innocent Bystander?

41. New Safety Concerns With Higher Dose Statin Therapy in Heart Transplantation: Time To Panic?

42. Functional and Structural Effects of Continuous-Flow Left Ventricular Assist Device Unloading on the Failing Human Heart: A Prospective, Single-Center Study

43. Biopsy-diagnosed antibody-mediated rejection based on the proposed International Society for Heart and Lung Transplantation working formulation is associated with adverse cardiovascular outcomes after pediatric heart transplant

45. A longitudinal study of the course of asymptomatic antibody-mediated rejection in heart transplantation

46. Allograft Rejection in Patients Supported With Continuous-Flow Left Ventricular Assist Devices

47. The intermountain risk score predicts incremental age-specific long-term survival and life expectancy

48. Red cell distribution width, C-reactive protein, the complete blood count, and mortality in patients with coronary disease and a normal comparison population

49. The Intermountain Risk Score Stratifies Mortality Risk in Heart Failure Patients Receiving an ICD Based on Pre-Implant Laboratory Values

50. Do Ischemic Cardiomyopathy and Cardiac Allograft Vasculopathy Have Unique Myocardial Remodeling Characteristics?

Catalog

Books, media, physical & digital resources